According to Zydus Lifesciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.37364. At the end of 2023 the company had a P/S ratio of 3.74.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.74 | 43.42% |
2022 | 2.61 | -21.4% |
2021 | 3.32 | -6.88% |
2020 | 3.57 | 89.57% |
2019 | 1.88 | -31.92% |
2018 | 2.76 | -31.35% |
2017 | 4.02 | 3.68% |
2016 | 3.88 | 9.6% |
2015 | 3.54 | -6.65% |
2014 | 3.79 | 60.88% |
2013 | 2.36 | -24.03% |
2012 | 3.10 |